<?xml version='1.0' encoding='utf-8'?>
<document id="19908205"><sentence text="Simultaneous RP-HPLC-DAD quantification of bromocriptine, haloperidol and its diazepane structural analog in rat plasma with droperidol as internal standard for application to drug-interaction pharmacokinetics."><entity charOffset="43-56" id="DDI-PubMed.19908205.s1.e0" text="bromocriptine" /><entity charOffset="58-69" id="DDI-PubMed.19908205.s1.e1" text="haloperidol" /><entity charOffset="78-87" id="DDI-PubMed.19908205.s1.e2" text="diazepane" /><entity charOffset="125-135" id="DDI-PubMed.19908205.s1.e3" text="droperidol" /><pair ddi="false" e1="DDI-PubMed.19908205.s1.e0" e2="DDI-PubMed.19908205.s1.e0" /><pair ddi="false" e1="DDI-PubMed.19908205.s1.e0" e2="DDI-PubMed.19908205.s1.e1" /><pair ddi="false" e1="DDI-PubMed.19908205.s1.e0" e2="DDI-PubMed.19908205.s1.e2" /><pair ddi="false" e1="DDI-PubMed.19908205.s1.e0" e2="DDI-PubMed.19908205.s1.e3" /><pair ddi="false" e1="DDI-PubMed.19908205.s1.e1" e2="DDI-PubMed.19908205.s1.e1" /><pair ddi="false" e1="DDI-PubMed.19908205.s1.e1" e2="DDI-PubMed.19908205.s1.e2" /><pair ddi="false" e1="DDI-PubMed.19908205.s1.e1" e2="DDI-PubMed.19908205.s1.e3" /><pair ddi="false" e1="DDI-PubMed.19908205.s1.e2" e2="DDI-PubMed.19908205.s1.e2" /><pair ddi="false" e1="DDI-PubMed.19908205.s1.e2" e2="DDI-PubMed.19908205.s1.e3" /></sentence><sentence text="A simple and rapid RP-HPLC-DAD method was developed and validated for simultaneous determination of the dopamine antagonists haloperidol, its diazepane analog, and the dopamine agonist bromocriptine in rat plasma, to perform pharmacokinetic drug-interaction studies"><entity charOffset="104-112" id="DDI-PubMed.19908205.s2.e0" text="dopamine" /><entity charOffset="125-136" id="DDI-PubMed.19908205.s2.e1" text="haloperidol" /><entity charOffset="142-151" id="DDI-PubMed.19908205.s2.e2" text="diazepane" /><entity charOffset="168-176" id="DDI-PubMed.19908205.s2.e3" text="dopamine" /><entity charOffset="185-198" id="DDI-PubMed.19908205.s2.e4" text="bromocriptine" /><pair ddi="false" e1="DDI-PubMed.19908205.s2.e0" e2="DDI-PubMed.19908205.s2.e0" /><pair ddi="false" e1="DDI-PubMed.19908205.s2.e0" e2="DDI-PubMed.19908205.s2.e1" /><pair ddi="false" e1="DDI-PubMed.19908205.s2.e0" e2="DDI-PubMed.19908205.s2.e2" /><pair ddi="false" e1="DDI-PubMed.19908205.s2.e0" e2="DDI-PubMed.19908205.s2.e3" /><pair ddi="false" e1="DDI-PubMed.19908205.s2.e0" e2="DDI-PubMed.19908205.s2.e4" /><pair ddi="false" e1="DDI-PubMed.19908205.s2.e1" e2="DDI-PubMed.19908205.s2.e1" /><pair ddi="false" e1="DDI-PubMed.19908205.s2.e1" e2="DDI-PubMed.19908205.s2.e2" /><pair ddi="false" e1="DDI-PubMed.19908205.s2.e1" e2="DDI-PubMed.19908205.s2.e3" /><pair ddi="false" e1="DDI-PubMed.19908205.s2.e1" e2="DDI-PubMed.19908205.s2.e4" /><pair ddi="false" e1="DDI-PubMed.19908205.s2.e2" e2="DDI-PubMed.19908205.s2.e2" /><pair ddi="false" e1="DDI-PubMed.19908205.s2.e2" e2="DDI-PubMed.19908205.s2.e3" /><pair ddi="false" e1="DDI-PubMed.19908205.s2.e2" e2="DDI-PubMed.19908205.s2.e4" /><pair ddi="false" e1="DDI-PubMed.19908205.s2.e3" e2="DDI-PubMed.19908205.s2.e3" /><pair ddi="false" e1="DDI-PubMed.19908205.s2.e3" e2="DDI-PubMed.19908205.s2.e4" /></sentence><sentence text=" Samples were prepared for analysis by acetonitrile (22"><entity charOffset="39-51" id="DDI-PubMed.19908205.s3.e0" text="acetonitrile" /></sentence><sentence text="0 microg/mL) plasma protein precipitation with droperidol as an internal standard, followed by a double-step liquid-liquid extraction with hexane : chloroform (70:30) prior to C-18 separation"><entity charOffset="47-57" id="DDI-PubMed.19908205.s4.e0" text="droperidol" /><entity charOffset="139-145" id="DDI-PubMed.19908205.s4.e1" text="hexane" /><entity charOffset="148-158" id="DDI-PubMed.19908205.s4.e2" text="chloroform" /><pair ddi="false" e1="DDI-PubMed.19908205.s4.e0" e2="DDI-PubMed.19908205.s4.e0" /><pair ddi="false" e1="DDI-PubMed.19908205.s4.e0" e2="DDI-PubMed.19908205.s4.e1" /><pair ddi="false" e1="DDI-PubMed.19908205.s4.e0" e2="DDI-PubMed.19908205.s4.e2" /><pair ddi="false" e1="DDI-PubMed.19908205.s4.e1" e2="DDI-PubMed.19908205.s4.e1" /><pair ddi="false" e1="DDI-PubMed.19908205.s4.e1" e2="DDI-PubMed.19908205.s4.e2" /></sentence><sentence text=" Isocratic elution was achieved using a 0" /><sentence text="1% (v/v) trifluoroacetic acid in deionized water, methanol and acetonitrile (45/27"><entity charOffset="9-29" id="DDI-PubMed.19908205.s6.e0" text="trifluoroacetic acid" /><entity charOffset="50-58" id="DDI-PubMed.19908205.s6.e1" text="methanol" /><entity charOffset="63-75" id="DDI-PubMed.19908205.s6.e2" text="acetonitrile" /><pair ddi="false" e1="DDI-PubMed.19908205.s6.e0" e2="DDI-PubMed.19908205.s6.e0" /><pair ddi="false" e1="DDI-PubMed.19908205.s6.e0" e2="DDI-PubMed.19908205.s6.e1" /><pair ddi="false" e1="DDI-PubMed.19908205.s6.e0" e2="DDI-PubMed.19908205.s6.e2" /><pair ddi="false" e1="DDI-PubMed.19908205.s6.e1" e2="DDI-PubMed.19908205.s6.e1" /><pair ddi="false" e1="DDI-PubMed.19908205.s6.e1" e2="DDI-PubMed.19908205.s6.e2" /></sentence><sentence text="5/27" /><sentence text="5, v/v/v)" /><sentence text=" Triple-wavelength diode-array detection at the lambda(max) of 245 nm for haloperidol, 254 nm for the diazepane analog and droperidol, and 240 nm for bromocriptine was carried out"><entity charOffset="74-85" id="DDI-PubMed.19908205.s9.e0" text="haloperidol" /><entity charOffset="102-111" id="DDI-PubMed.19908205.s9.e1" text="diazepane" /><entity charOffset="123-133" id="DDI-PubMed.19908205.s9.e2" text="droperidol" /><entity charOffset="150-163" id="DDI-PubMed.19908205.s9.e3" text="bromocriptine" /><pair ddi="false" e1="DDI-PubMed.19908205.s9.e0" e2="DDI-PubMed.19908205.s9.e0" /><pair ddi="false" e1="DDI-PubMed.19908205.s9.e0" e2="DDI-PubMed.19908205.s9.e1" /><pair ddi="false" e1="DDI-PubMed.19908205.s9.e0" e2="DDI-PubMed.19908205.s9.e2" /><pair ddi="false" e1="DDI-PubMed.19908205.s9.e0" e2="DDI-PubMed.19908205.s9.e3" /><pair ddi="false" e1="DDI-PubMed.19908205.s9.e1" e2="DDI-PubMed.19908205.s9.e1" /><pair ddi="false" e1="DDI-PubMed.19908205.s9.e1" e2="DDI-PubMed.19908205.s9.e2" /><pair ddi="false" e1="DDI-PubMed.19908205.s9.e1" e2="DDI-PubMed.19908205.s9.e3" /><pair ddi="false" e1="DDI-PubMed.19908205.s9.e2" e2="DDI-PubMed.19908205.s9.e2" /><pair ddi="false" e1="DDI-PubMed.19908205.s9.e2" e2="DDI-PubMed.19908205.s9.e3" /></sentence><sentence text=" The LLOQ of DAL, HAL, and BCT were 45" /><sentence text="0, 56" /><sentence text="1, and 150 ng/mL, respectively" /><sentence text=" In rats, the estimated pharmacokinetic parameters (i" /><sentence text="e" /><sentence text=", t(1/2), CL, and V(ss)) of HAL when administered with DAL and BCT were t(1/2) = 16"><entity charOffset="10-12" id="DDI-PubMed.19908205.s15.e0" text="CL" /></sentence><sentence text="4 min, V(ss) = 0" /><sentence text="541 L/kg for HAL, t(1/2) = 28" /><sentence text="0 min, V(ss) = 2" /><sentence text="00 L/kg for DAL, and t(1/2) = 24" /><sentence text="0 min, V(ss) = 0" /><sentence text="106 L/kg for BCT" /><sentence text=" The PK parameters for HAL differed significantly from those previously reported, which may be an indication of a drug-drug interaction" /><sentence text="" /></document>